Literature DB >> 28101959

Comprehensive Analysis of Transcript Changes Associated With Allograft Rejection: Combining Universal and Selective Features.

P F Halloran1,2, J M Venner1, K S Famulski1,3.   

Abstract

We annotated the top transcripts associated with kidney transplant rejection by p-value, either universal for all rejection or selective for T cell-mediated rejection (TCMR) or antibody-mediated rejection (ABMR; ClinicalTrials.gov NCT01299168). We used eight class-comparison algorithms to interrogate microarray results from 703 biopsies, 205 with rejection. The positive comparators were all rejection, TCMR, or ABMR; the negative comparators varied from normal biopsies to all nonrejecting biopsies, including other diseases. The universal algorithm, rejection versus all nonrejection, identified transcripts mainly inducible by interferon γ. Selectivity for ABMR or TCMR required the other rejection class as well as nonrejection biopsies in the comparator to avoid selecting universal transcripts. Direct comparison of ABMR versus TCMR yielded only transcripts related to TCMR, the stronger signal. Transcripts highly associated with rejection were never completely specific for rejection: Many were increased in biopsies without rejection, reflecting sharing between rejection and injury-induced innate immunity. Union of the top 200 transcripts from universal and selective algorithms yielded 454 transcripts that permitted unsupervised analysis of biopsies in principal component analysis: PC1 was rejection, and PC2 was separation of TCMR from ABMR. Appreciating rejection-associated molecular changes requires a diverse case mix, accurate histologic classification (including C4d-negative ABMR), and both selective and universal algorithms.
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  basic (laboratory) research/science; biopsy; kidney transplantation/nephrology; rejection; rejection: T cell mediated (TCMR); rejection: antibody-mediated (ABMR)

Mesh:

Substances:

Year:  2017        PMID: 28101959     DOI: 10.1111/ajt.14200

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  22 in total

1.  Key driver genes as potential therapeutic targets in renal allograft rejection.

Authors:  Zhengzi Yi; Karen L Keung; Li Li; Min Hu; Bo Lu; Leigh Nicholson; Elvira Jimenez-Vera; Madhav C Menon; Chengguo Wei; Stephen Alexander; Barbara Murphy; Philip J O'Connell; Weijia Zhang
Journal:  JCI Insight       Date:  2020-08-06

2.  Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes.

Authors:  Jeff Reeve; Georg A Böhmig; Farsad Eskandary; Gunilla Einecke; Carmen Lefaucheur; Alexandre Loupy; Philip F Halloran
Journal:  JCI Insight       Date:  2017-06-15

3.  Multi-gene technical assessment of qPCR and NanoString n-Counter analysis platforms in cynomolgus monkey cardiac allograft recipients.

Authors:  Emily A S Bergbower; Richard N Pierson; Agnes M Azimzadeh
Journal:  Cell Immunol       Date:  2019-11-08       Impact factor: 4.868

4.  Kidney Biopsy Findings in Patients with COVID-19.

Authors:  Satoru Kudose; Ibrahim Batal; Dominick Santoriello; Katherine Xu; Jonathan Barasch; Yonatan Peleg; Pietro Canetta; Lloyd E Ratner; Maddalena Marasa; Ali G Gharavi; M Barry Stokes; Glen S Markowitz; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2020-07-17       Impact factor: 10.121

5.  High Dimensional Renal Profiling: Towards a Better Understanding or Renal Transplant Immune Suppression.

Authors:  Cyd M Castro-Rojas; Rita R Alloway; E Steve Woodle; David A Hildeman
Journal:  Curr Transplant Rep       Date:  2019-01-14

6.  WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failure.

Authors:  Michael E Seifert; Joseph P Gaut; Boyi Guo; Sanjay Jain; Andrew F Malone; Feargal Geraghty; Deborah L Della Manna; Eddy S Yang; Nengjun Yi; Daniel C Brennan; Roslyn B Mannon
Journal:  Am J Transplant       Date:  2019-05-10       Impact factor: 8.086

7.  Exploring the cardiac response to injury in heart transplant biopsies.

Authors:  Philip F Halloran; Jeff Reeve; Arezu Z Aliabadi; Martin Cadeiras; Marisa G Crespo-Leiro; Mario Deng; Eugene C Depasquale; Johannes Goekler; Xavier Jouven; Daniel H Kim; Jon Kobashigawa; Alexandre Loupy; Peter Macdonald; Luciano Potena; Andreas Zuckermann; Michael D Parkes
Journal:  JCI Insight       Date:  2018-10-18

Review 8.  Transplant glomerulopathy.

Authors:  Edward J Filippone; Peter A McCue; John L Farber
Journal:  Mod Pathol       Date:  2017-10-13       Impact factor: 7.842

9.  The evolution of patient-specific precision biomarkers to guide personalized heart-transplant care.

Authors:  Mario C Deng
Journal:  Expert Rev Precis Med Drug Dev       Date:  2020-10-28

10.  Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection.

Authors:  Katelynn S Madill-Thomsen; Georg A Böhmig; Jonathan Bromberg; Gunilla Einecke; Farsad Eskandary; Gaurav Gupta; Luis G Hidalgo; Marek Myslak; Ondrej Viklicky; Agnieszka Perkowska-Ptasinska; Philip F Halloran
Journal:  J Am Soc Nephrol       Date:  2021-07-12       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.